Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.

Hang Zhou,Jianru Li,Libin Hu,Jiahui Yu,Xiongjie Fu,Feng Liang,Feng Yan,Gao Chen
DOI: https://doi.org/10.1016/j.jare.2022.03.011
IF: 12.822
2023-01-01
Journal of Advanced Research
Abstract:These findings indicate sTrem2 as a negative factor against microglia/macrophage-mediated hematoma and related neuronal damage clearance, provide insight into the mechanisms by which erythrophagocytosis is regulated and how it may be impaired after ICH, and suggest that the anti-proteolytic activity of Trem2 can be explored for ICH therapy.
What problem does this paper attempt to address?